3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Multiple Myeloma
186
Lymphoma, Large B-Cell, Diffuse
41
Leukemia, Lymphocytic, Chronic, B-Cell
41
Recurrence
28
Neoplasms, Plasma Cell
27
Lymphoma
25
Lymphoma, Mantle-Cell
23
Lymphoma, Follicular
23
Leukemia
20
Lymphoma, B-Cell, Marginal Zone
15
Lymphoma, Non-Hodgkin
14
Leukemia, Myeloid, Acute
13
Smoldering Multiple Myeloma
9
Myelodysplastic Syndromes
9
Lymphoma, T-Cell, Peripheral
7
Lymphoma, B-Cell
7
Waldenstrom Macroglobulinemia
6
Neoplasms
6
Neoplasm, Residual
6
Immunoglobulin Light-chain Amyloidosis
6
Lymphoma, T-Cell
5
Leukemia, Plasma Cell
5
Leukemia, Myelomonocytic, Chronic
5
Renal Insufficiency
4
Prostatic Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma, T-Cell, Cutaneous
4
Hodgkin Disease
4
Hematologic Diseases
4
Sezary Syndrome
3
Interventions
Vincristine
5
Methotrexate
5
Dexamethasone
5
Cytarabine
5
Cyclophosphamide
5
Inotuzumab Ozogamicin
4
blinatumomab
3
Rituximab
3
Prednisone
3
Doxorubicin
3
venetoclax
2
prednylidene
2
pegaspargase
2
merphos
2
deltacortene
2
Mercaptopurine
2
Asparaginase
2
olverembatinib
1
ofatumumab
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
calaspargase pegol
1
azathiopurine
1
auricularum
1
asparaginase erwinia chrysanthemi recombinant
1
X-Rays
1
Spinal Puncture
1
Specimen Handling
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Methylprednisolone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
×
Lenalidomide
×
Clear all
NCT01116193
2017-09-14
RV-405 LAL
Institut de Cancérologie de la Loire
Phase 2
Completed
10 enrolled